cytomegalovirus infection
Showing 1 - 25 of 44
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Birmingham, Alabama
- +25 more
Nov 10, 2023
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Completed
- Sensorineural Hearing Loss
- Cytomegalovirus Infection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Cytomegalovirus Infection Trial in Worldwide (mRNA-1647, Placebo)
Recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Phoenix, Arizona
- +165 more
Jan 13, 2023
Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 4, 2023
Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)
Completed
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Sacramento, California
- +8 more
Jan 11, 2023
Cytomegalovirus Infection Trial in North Hollywood, San Diego, Honolulu (mRNA-1647, Placebo)
Active, not recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
North Hollywood, California
- +2 more
Dec 3, 2022
Cytomegalovirus Infection Trial in United States (DBS Self-Collection Kit, Standard Control Strategy)
Recruiting
- Cytomegalovirus Infection
- DBS Self-Collection Kit
- Standard Control Strategy
-
Minneapolis, Minnesota
- +3 more
Aug 18, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Cytomegalovirus Infection Trial in United States (Valganciclovir)
Completed
- Cytomegalovirus Infection
-
Los Angeles, California
- +5 more
Jul 29, 2021
Cytomegalovirus Infection Trial in United States (Brincidofovir, Placebo)
Cytomegalovirus Infection Trial in United Kingdom, United States (Placebo, Valganciclovir)
Glioblastoma Multiforme, Cytomegalovirus Infection Trial in Solna, Umea, Uppsala (Valganciclovir (Valcyte), Placebo)
Completed
- Glioblastoma Multiforme
- Cytomegalovirus Infection
- Valganciclovir (Valcyte)
- Placebo
-
Solna, Stockholm, Sweden
- +2 more
Feb 25, 2021
Cytomegalovirus Infection Trial in United States (mRNA-1647, mRNA-1443, Placebo)
Completed
- Cytomegalovirus Infection
- mRNA-1647
- +2 more
-
Hollywood, Florida
- +3 more
Jan 13, 2021
Cytomegalovirus Infection, Adenovirus Infection Trial in Vienna (virus-specific T-Cells)
Withdrawn
- Cytomegalovirus Infection
- Adenovirus Infection
- virus-specific T-Cells
-
Vienna, AustriaSt. Anna Children's Hospital
May 7, 2019
Transplantation Infection, Cytomegalovirus Infection Trial in France (Everolimus, mycophenolic acid)
Completed
- Transplantation Infection
- Cytomegalovirus Infection
- Everolimus
- mycophenolic acid
-
Bordeaux, France
- +8 more
Nov 12, 2018
Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients
Completed
- Cytomegalovirus Infection
- GVHD
-
Regensburg, GermanyUniversitätsklinikum Regensburg
Aug 7, 2018
Cytomegalovirus Infection Trial in Ghent (Low dose HB-101, Medium dose HB-101, High dose HB-101)
Completed
- Cytomegalovirus Infection
- Low dose HB-101
- +3 more
-
Ghent, East Flanders, BelgiumCenter for Vaccinology Ghent
Apr 1, 2018
Cytomegalovirus Infection Trial in United Kingdom (CMV-specific T-cells, single infusion following single positive CMV PCR
Completed
- Cytomegalovirus Infection
- CMV-specific T-cells, single infusion following single positive CMV PCR result
-
Birmingham, United Kingdom
- +8 more
Jan 23, 2018
Cytomegalovirus Infection Trial in United Kingdom (Adoptive Cellular Therapy, Best available antiviral drug therapy)
Completed
- Cytomegalovirus Infection
- Adoptive Cellular Therapy
- Best available antiviral drug therapy
-
Birmingham, West Midlands, United Kingdom
- +13 more
Jan 23, 2018
Cytomegalovirus Infection Trial in Decatur (MBX400, Placebo)
Completed
- Cytomegalovirus Infection
- MBX400
- Placebo
-
Decatur, GeorgiaEmory Vaccine Center - The Hope Clinic
Dec 21, 2017
Cytomegalovirus Infection, Healthy, no Evidence of Disease Trial in Duarte (multi-CMV epitope modified vaccinia Ankara vaccine,
Completed
- Cytomegalovirus Infection
- Healthy, no Evidence of Disease
- multi-CMV epitope modified vaccinia Ankara vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 31, 2017
Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive
Unknown status
- Cytomegalovirus Infection
- HSCT
-
Santander, Cantabria, Spain
- +1 more
Jul 4, 2017